Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study‘
Maria De Santis, Antonio Voza, Victor Savevski, Salvatore Badalamenti, Maurizio Cecconi, Alberto Mantovani, Carlo Selmi
Topics & Concepts
TocilizumabMedicineCytokine stormMethylprednisolonePneumoniaMechanical ventilationCytokine release syndromeInternal medicineCoronavirus disease 2019 (COVID-19)Rheumatoid arthritisDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders